Literature DB >> 16495330

Incorporation of orally applied (13)C-galactose into milk lactose and oligosaccharides.

Silvia Rudloff1, Susanne Obermeier, Christian Borsch, Gottfried Pohlentz, Rudolf Hartmann, Herbert Brösicke, Michael J Lentze, Clemens Kunz.   

Abstract

Biosynthesis and functions of human milk oligosaccharides (HMO) are not well known. A typical housekeeping enzyme, beta1,4-galactosyltransferase, links galactose to glucose to form lactose which is then used as backbone for the assembly of HMO. We investigated whether milk lactose and HMO may be labeled in vivo by an orally given (13)C-galactose bolus. Eleven exclusively breastfeeding mothers were given a (13)C-galactose bolus at the end of their breakfast. Milk and urine samples from each nursing up to 36 h were analyzed for carbohydrate composition by high-performance thin-layer chromatography, high-pH anion-exchange chromatography, and fast atom bombardment mass spectrometry. (13)C enrichment of milk fractions, urinary carbohydrates, lactose, and oligosaccharides as well as of breath CO(2) was determined by isotope ratio mass spectrometry. Up to 10% of the orally given galactose bolus was directly transported to the mammary gland and incorporated into milk components. Characteristic for most milk samples was the appearance of two (13)C-peaks, the first immediately after the (13)C-bolus was taken and the second on the next morning. The highest (13)C enrichment was found in lactose followed by neutral and acidic oligosaccharides. In breath samples, the (13)C-excretion followed the same pattern as in milk. (13)C nuclear magnetic resonance of isolated lactose revealed (13)C only at C(1)-atom of galactose and C(1)-atom of glucose. This label was without any exception at the same position as the (13)C-label of the orally applied galactose. Neutral and acidic HMO can easily be (13)C-labeled in vivo which facilitates investigations of their metabolic fate in infants.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495330     DOI: 10.1093/glycob/cwj092

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  21 in total

1.  Human milk oligosaccharides protect bladder epithelial cells against uropathogenic Escherichia coli invasion and cytotoxicity.

Authors:  Ann E Lin; Chloe A Autran; Sophia D Espanola; Lars Bode; Victor Nizet
Journal:  J Infect Dis       Date:  2013-08-29       Impact factor: 5.226

Review 2.  Human milk oligosaccharides: every baby needs a sugar mama.

Authors:  Lars Bode
Journal:  Glycobiology       Date:  2012-04-18       Impact factor: 4.313

3.  Human milk oligosaccharides inhibit growth of group B Streptococcus.

Authors:  Ann E Lin; Chloe A Autran; Alexandra Szyszka; Tamara Escajadillo; Mia Huang; Kamil Godula; Anthony R Prudden; Geert-Jan Boons; Amanda L Lewis; Kelly S Doran; Victor Nizet; Lars Bode
Journal:  J Biol Chem       Date:  2017-04-17       Impact factor: 5.157

4.  Metabolic flux analysis of the neural cell glycocalyx reveals differential utilization of monosaccharides.

Authors:  Maurice Wong; Gege Xu; Mariana Barboza; Izumi Maezawa; Lee-Way Jin; Angela Zivkovic; Carlito B Lebrilla
Journal:  Glycobiology       Date:  2020-10-21       Impact factor: 4.313

Review 5.  Historical aspects of human milk oligosaccharides.

Authors:  Clemens Kunz
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

Review 6.  Milk oligosaccharides and metabolism in infants.

Authors:  Silvia Rudloff; Clemens Kunz
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

7.  Transcriptome profiling of bovine milk oligosaccharide metabolism genes using RNA-sequencing.

Authors:  Saumya Wickramasinghe; Serenus Hua; Gonzalo Rincon; Alma Islas-Trejo; J Bruce German; Carlito B Lebrilla; Juan F Medrano
Journal:  PLoS One       Date:  2011-04-25       Impact factor: 3.240

8.  Transcriptional profiling of bovine milk using RNA sequencing.

Authors:  Saumya Wickramasinghe; Gonzalo Rincon; Alma Islas-Trejo; Juan F Medrano
Journal:  BMC Genomics       Date:  2012-01-25       Impact factor: 3.969

9.  Safety of 3-FL (3-Fucosyllactose) as a novel food pursuant to Regulation (EU) 2015/2283.

Authors:  Dominique Turck; Jacqueline Castenmiller; Stefaan De Henauw; Karen Ildico Hirsch-Ernst; John Kearney; Alexandre Maciuk; Inge Mangelsdorf; Harry J McArdle; Androniki Naska; Carmen Pelaez; Kristina Pentieva; Alfonso Siani; Frank Thies; Sophia Tsabouri; Marco Vinceti; Francesco Cubadda; Thomas Frenzel; Marina Heinonen; Rosangela Marchelli; Monika Neuhäuser-Berthold; Morten Poulsen; Miguel Prieto Maradona; Josef Rudolf Schlatter; Henk van Loveren; Paolo Colombo; Helle Katrine Knutsen
Journal:  EFSA J       Date:  2021-06-30

Review 10.  A Comparative Review of the Cell Biology, Biochemistry, and Genetics of Lactose Synthesis.

Authors:  Anna Sadovnikova; Sergio C Garcia; Russell C Hovey
Journal:  J Mammary Gland Biol Neoplasia       Date:  2021-06-14       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.